These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 27982029)

  • 1. GALNT14 promotes lung-specific breast cancer metastasis by modulating self-renewal and interaction with the lung microenvironment.
    Song KH; Park MS; Nandu TS; Gadad S; Kim SC; Kim MY
    Nat Commun; 2016 Dec; 7():13796. PubMed ID: 27982029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of GALNT14 in lung metastasis of breast cancer.
    Kim MY
    BMB Rep; 2017 May; 50(5):233-234. PubMed ID: 28347399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GALNT14 in association with GDF-15 promotes stemness and drug resistance through β-catenin signalling pathway in breast cancer.
    Gadwal A; Purohit P; Khokhar M; Vishnoi JR; Pareek P; Choudhary R; Elhence P; Banerjee M; Sharma P
    Mol Biol Rep; 2024 May; 51(1):691. PubMed ID: 38796671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GALNT14 mediates tumor invasion and migration in breast cancer cell MCF-7.
    Huanna T; Tao Z; Xiangfei W; Longfei A; Yuanyuan X; Jianhua W; Cuifang Z; Manjing J; Wenjing C; Shaochuan Q; Feifei X; Naikang L; Jinchao Z; Chen W
    Mol Carcinog; 2015 Oct; 54(10):1159-71. PubMed ID: 24962947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osterix Decreases the Chemosensitivity of Breast Cancer Cells by Upregulating GALNT14.
    Wu J; Chen X; Bao Q; Duan R; Jin Y; Shui Y; Yao B; Lu X; Wang Y; Cui H; Li L; Yuan H; Ma C
    Cell Physiol Biochem; 2017; 44(3):998-1010. PubMed ID: 29227978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GALNT6, GALNT14, and Gal-3 in association with GDF-15 promotes drug resistance and stemness of breast cancer
    Gadwal A; Purohit P; Khokhar M; Vishnoi JR; Pareek P; Choudhary R; Elhence P; Banerjee M; Sharma P
    Growth Factors; 2024 May; 42(2):84-100. PubMed ID: 38889447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LAMTOR5 raises abnormal initiation of O-glycosylation in breast cancer metastasis via modulating GALNT1 activity.
    Fang R; Xu F; Shi H; Wu Y; Cao C; Li H; Ye K; Zhang Y; Liu Q; Zhang S; Zhang W; Ye L
    Oncogene; 2020 Mar; 39(11):2290-2304. PubMed ID: 31836847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-125a regulates ovarian cancer proliferation and invasion by repressing GALNT14 expression.
    Yang J; Li G; Zhang K
    Biomed Pharmacother; 2016 May; 80():381-387. PubMed ID: 27133078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of GALNT8 and O-glycosylation of BMP receptor 1A suppress breast cancer cell proliferation by upregulating ERα levels.
    Huang T; Wu Q; Huang H; Zhang C; Wang L; Wang L; Liu Y; Li W; Zhang J; Liu Y
    Biochim Biophys Acta Gen Subj; 2022 Jan; 1866(1):130046. PubMed ID: 34743989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer.
    Kwon OS; Lee H; Kong HJ; Kwon EJ; Park JE; Lee W; Kang S; Kim M; Kim W; Cha HJ
    Oncogene; 2020 Jun; 39(23):4567-4580. PubMed ID: 32388539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mucin-type glycosylating enzyme polypeptide N-acetylgalactosaminyltransferase 14 promotes the migration of ovarian cancer by modifying mucin 13.
    Wang R; Yu C; Zhao D; Wu M; Yang Z
    Oncol Rep; 2013 Aug; 30(2):667-76. PubMed ID: 23708057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GALNT14-mediated O-glycosylation on PHB2 serine-161 enhances cell growth, migration and drug resistance by activating IGF1R cascade in hepatoma cells.
    Chu YD; Fan TC; Lai MW; Yeh CT
    Cell Death Dis; 2022 Nov; 13(11):956. PubMed ID: 36376274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential Proteome Analysis Identifies TGF-β-Related Pro-Metastatic Proteins in a 4T1 Murine Breast Cancer Model.
    Sato M; Matsubara T; Adachi J; Hashimoto Y; Fukamizu K; Kishida M; Yang YA; Wakefield LM; Tomonaga T
    PLoS One; 2015; 10(5):e0126483. PubMed ID: 25993439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mint3 in bone marrow-derived cells promotes lung metastasis in breast cancer model mice.
    Hara T; Murakami Y; Seiki M; Sakamoto T
    Biochem Biophys Res Commun; 2017 Aug; 490(3):688-692. PubMed ID: 28634075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reductions in myeloid-derived suppressor cells and lung metastases using AZD4547 treatment of a metastatic murine breast tumor model.
    Liu L; Ye TH; Han YP; Song H; Zhang YK; Xia Y; Wang NY; Xiong Y; Song XJ; Zhu YX; Li de L; Zeng J; Ran K; Peng CT; Wei YQ; Yu LT
    Cell Physiol Biochem; 2014; 33(3):633-45. PubMed ID: 24642893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel cinnamide YLT26 induces breast cancer cells apoptosis via ROS-mitochondrial apoptotic pathway in vitro and inhibits lung metastasis in vivo.
    Xiong Y; Ye T; Wang M; Xia Y; Wang N; Song X; Wang F; Liu L; Zhu Y; Yang F; Wei Y; Yu L
    Cell Physiol Biochem; 2014; 34(6):1863-76. PubMed ID: 25503322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of immunohistochemistry assays to assess GALNT14 and FUT3/6 in clinical trials of dulanermin and drozitumab.
    Stern HM; Padilla M; Wagner K; Amler L; Ashkenazi A
    Clin Cancer Res; 2010 Mar; 16(5):1587-96. PubMed ID: 20179215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer Cell-derived Secretory Factors in Breast Cancer-associated Lung Metastasis: Their Mechanism and Future Prospects.
    Urooj T; Wasim B; Mushtaq S; Shah SNN; Shah M
    Curr Cancer Drug Targets; 2020; 20(3):168-186. PubMed ID: 31858911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fascin Is Critical for the Maintenance of Breast Cancer Stem Cell Pool Predominantly via the Activation of the Notch Self-Renewal Pathway.
    Barnawi R; Al-Khaldi S; Majed Sleiman G; Sarkar A; Al-Dhfyan A; Al-Mohanna F; Ghebeh H; Al-Alwan M
    Stem Cells; 2016 Dec; 34(12):2799-2813. PubMed ID: 27502039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl-x(L)-mediated changes in metabolic pathways of breast cancer cells: from survival in the blood stream to organ-specific metastasis.
    España L; Martín B; Aragüés R; Chiva C; Oliva B; Andreu D; Sierra A
    Am J Pathol; 2005 Oct; 167(4):1125-37. PubMed ID: 16192647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.